Aspen Aerogels
ASPN
53 hedge funds and large institutions have $105M invested in Aspen Aerogels in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 10 closing their positions.
31% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 13
19% more capital invested
Capital invested by funds: $88.1M → $105M (+$16.5M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.99% less ownership
Funds ownership: 76.32% → 75.32% (-0.99%)
9% less funds holding
Funds holding: 58 → 53 (-5)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Top Buyers
Top Sellers
ASPN Hedge Fund Activity: Q3 2016 in Review
53 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Aspen Aerogels (ASPN) for Q3 2016, worth a combined $105M — up 19% from $88.1M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ASPN and 5 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 17 added.
The largest buyer was Ariel Investments, opening a new position worth an estimated $3.64M. The largest seller was Fidelity Investments, exiting entirely with an estimated $7.21M sold.
- 53 institutional investors held Aspen Aerogels (ASPN) as of Q3 2016, down from 58 in Q2 2016.
- Funds reported $105M of Aspen Aerogels stock for Q3 2016, up 19% quarter-over-quarter.
- 5 funds opened new Aspen Aerogels positions in Q3 2016 and 10 closed out, a net change of -5 holders.
- The largest Aspen Aerogels buyer in Q3 2016 was Ariel Investments, an estimated $3.64M added.
- The largest Aspen Aerogels seller in Q3 2016 was Fidelity Investments, an estimated $7.21M sold.
Based on aggregated 13F filings for Q3 2016.